ArticleJournal of neurology2026

Prediction of short-term and long-term responses to cladribine in relapsing-remitting multiple sclerosis: a Danish nationwide real-world study.

Stephan Bramow et al.PubMed ↗Publisher ↗

No numbers read from the abstract.